ELAVL1 and cancer: SUMOylation of HuR promotes major cancer hallmarks, namely proliferation and invasion, whereas the absence of HuR SUMOylation triggers a senescent phenotype with damaged mitochondrial and endoplasmic reticulum (ER) structure and function.